PHARMACOKINETICS OF FLUOROQUINOLONES IN HEPATIC-FAILURE

被引:20
作者
MONTAY, G
GAILLOT, J
机构
[1] Institut de Biopharmacie, Rhône-Poulenc Santé, 92165, Antony Cedex
关键词
D O I
10.1093/jac/26.suppl_B.61
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In patients with alcoholic cirrhosis, the phannacokinetics of the fluoroquinolones were variously altered. The kinetics of ciprofloxacin were slightly modified in patients with mild or moderate impairment. Ofloxacin kinetics were influenced by renal dysfunction encountered in patients with ascites. Pefloxacin kinetics were markedly modified with wide variations in elimination among patients. Ascitic penetration of ofloxacin and pefloxacin was excellent. Since no relationship between ofloxacin or pefloxacin kinetics and the usual livei function tests was found, recommended dosage regimens in cirrhotic patients have to be controlled by monitoring plasma drug levels during treatment. © 1990 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 17 条
[1]   ORAL PHARMACOKINETICS AND ASCITIC FLUID PENETRATION OF PEFLOXACIN IN CIRRHOSIS [J].
CARDEY, J ;
SILVAIN, C ;
BOUQUET, S ;
BREUX, JP ;
BECQGIRAUDON, B ;
FOURTILLAN, JP ;
BEAUCHANT, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (05) :469-472
[2]  
COLLIGNON F, 1987, LIVER CELLS DRUGS, V164, P253
[3]   PEFLOXACIN KINETICS IN CIRRHOSIS [J].
DANAN, G ;
MONTAY, G ;
CUNCI, R ;
ERLINGER, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :439-442
[4]  
ESPOSITO S, 1989, INT J CLIN PHARM RES, V9, P37
[5]   THE EFFECT OF CIRRHOSIS ON THE STEADY-STATE PHARMACOKINETICS OF ORAL CIPROFLOXACIN [J].
FROST, RW ;
LETTIERI, JT ;
KROL, G ;
SHAMBLEN, EC ;
LASSETER, KC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (06) :608-616
[6]   PHARMACOKINETICS OF PEFLOXACIN AFTER REPEATED INTRAVENOUS AND ORAL-ADMINISTRATION (400-MG BID) IN YOUNG HEALTHY-VOLUNTEERS [J].
FRYDMAN, AM ;
LEROUX, Y ;
LEFEBVRE, MA ;
DJEBBAR, F ;
FOURTILLAN, JB ;
GAILLOT, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 :65-79
[7]  
GALTIER M, 1988, 3EMES J MED PHARM MO, P630
[8]  
JOCHEMSEN R, 1986, 3RD WORLD C CLIN PHA
[9]  
MAHR G, 1988, 28TH INT C ANT AG CH
[10]   THE QUINOLONES - AN OVERVIEW AND COMPARATIVE APPRAISAL OF THEIR PHARMACOKINETICS AND PHARMACODYNAMICS [J].
NIX, DE ;
SCHENTAG, JJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (02) :169-178